• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

与人类免疫缺陷病毒（HIV）颗粒和马传染性贫血病毒核心相关的拓扑异构酶I活性。

Topoisomerase I activity associated with human immunodeficiency virus (HIV) particles and equine infectious anemia virus core.

作者信息

Priel E, Showalter S D, Roberts M, Oroszlan S, Segal S, Aboud M, Blair D G

机构信息

Microbiology and Immunology Unit, Faculty of Health Sciences, Ben-Gurion University, Beer-Sheva, Israel.

出版信息

EMBO J. 1990 Dec;9(12):4167-72. doi: 10.1002/j.1460-2075.1990.tb07640.x.

DOI:10.1002/j.1460-2075.1990.tb07640.x
PMID:2174357
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC552192/
Abstract

In the present study, we found a topoisomerase I (topo I) activity in two strains of human immunodeficiency virus type 1 (HIV-1) and equine infectious anemia virus (EIAV) particles. The topo I activity was located in the EIAV cores and differed from the cellular topo I in its ionic requirements and response to ATP, indicating that these were two distinct forms of this enzyme. Topo I activity was removed from the viral lysates and viral cores by anti-topo I antiserum. The only protein recognized by this antiserum was an 11.5 kd protein in HIV lysate and 11 kd in EIAV lysate. We showed that the 11 kd protein recognized by the anti-topo I antiserum is the EIAV p11 nucleocapsid protein. Furthermore, purified topo I protein blocked the binding of the antibodies to the p11 protein and vice versa, purified p11 protein blocked the binding of these antibodies to the cellular topo I. These results suggest that the EIAV p11 nucleocapsid protein and the cellular topo I share similar epitopes.

摘要

在本研究中，我们在两株1型人类免疫缺陷病毒（HIV-1）和马传染性贫血病毒（EIAV）颗粒中发现了拓扑异构酶I（topo I）活性。拓扑异构酶I活性位于EIAV核心内，其离子需求和对ATP的反应不同于细胞拓扑异构酶I，这表明这是该酶的两种不同形式。通过抗拓扑异构酶I抗血清从病毒裂解物和病毒核心中去除拓扑异构酶I活性。该抗血清识别的唯一蛋白质在HIV裂解物中为11.5 kd蛋白，在EIAV裂解物中为11 kd蛋白。我们发现抗拓扑异构酶I抗血清识别的11 kd蛋白是EIAV p11核衣壳蛋白。此外，纯化的拓扑异构酶I蛋白可阻断抗体与p11蛋白的结合，反之亦然，纯化的p11蛋白可阻断这些抗体与细胞拓扑异构酶I的结合。这些结果表明，EIAV p11核衣壳蛋白与细胞拓扑异构酶I具有相似的表位。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f4a8/552192/8c449b36ef10/emboj00239-0361-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f4a8/552192/7af9bfc46b73/emboj00239-0358-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f4a8/552192/65c0f54d4fbc/emboj00239-0358-b.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f4a8/552192/34ad600b95d3/emboj00239-0358-c.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f4a8/552192/102d7e499728/emboj00239-0359-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f4a8/552192/0ff69a9dd804/emboj00239-0359-b.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f4a8/552192/31c325b00bf4/emboj00239-0360-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f4a8/552192/8c449b36ef10/emboj00239-0361-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f4a8/552192/7af9bfc46b73/emboj00239-0358-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f4a8/552192/65c0f54d4fbc/emboj00239-0358-b.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f4a8/552192/34ad600b95d3/emboj00239-0358-c.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f4a8/552192/102d7e499728/emboj00239-0359-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f4a8/552192/0ff69a9dd804/emboj00239-0359-b.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f4a8/552192/31c325b00bf4/emboj00239-0360-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f4a8/552192/8c449b36ef10/emboj00239-0361-a.jpg

相似文献

1
Topoisomerase I activity associated with human immunodeficiency virus (HIV) particles and equine infectious anemia virus core.与人类免疫缺陷病毒（HIV）颗粒和马传染性贫血病毒核心相关的拓扑异构酶I活性。
EMBO J. 1990 Dec;9(12):4167-72. doi: 10.1002/j.1460-2075.1990.tb07640.x.
2
Isolation of an 11-kDa protein associated with the topoisomerase I activity from equine infectious anemia virus.从马传染性贫血病毒中分离出一种与拓扑异构酶I活性相关的11千道尔顿蛋白。
Biochem Biophys Res Commun. 1996 Mar 27;220(3):1028-35. doi: 10.1006/bbrc.1996.0527.
3
Human immunodeficiency virus type 1 reverse transcriptase: enhancement of activity by interaction with cellular topoisomerase I.1型人类免疫缺陷病毒逆转录酶：与细胞拓扑异构酶I相互作用增强活性
Proc Natl Acad Sci U S A. 1995 Jun 6;92(12):5694-8. doi: 10.1073/pnas.92.12.5694.
4
Purification and partial characterization of equine infectious anemia virus reverse transcriptase.马传染性贫血病毒逆转录酶的纯化及部分特性分析
Virology. 1991 Nov;185(1):387-94. doi: 10.1016/0042-6822(91)90786-b.
5
Expression, characterisation and mutagenesis of the aspartic proteinase from equine infectious anaemia virus.马传染性贫血病毒天冬氨酸蛋白酶的表达、特性鉴定及诱变
Eur J Biochem. 1996 Oct 15;241(2):664-74. doi: 10.1111/j.1432-1033.1996.00664.x.
6
Studies on the substrate specificity of the proteinase of equine infectious anemia virus using oligopeptide substrates.使用寡肽底物对马传染性贫血病毒蛋白酶的底物特异性研究。
Biochemistry. 1993 Apr 6;32(13):3347-53. doi: 10.1021/bi00064a018.
7
Expression and mutational analysis of the reverse transcriptase of the lentivirus equine infectious anemia virus.马传染性贫血病毒慢病毒逆转录酶的表达及突变分析
Biochem Biophys Res Commun. 1993 Oct 29;196(2):914-20. doi: 10.1006/bbrc.1993.2336.
8
Replication in vitro and in vivo of an equine infectious anemia virus mutant deficient in dUTPase activity.缺乏dUTPase活性的马传染性贫血病毒突变体在体外和体内的复制
J Virol. 1995 May;69(5):2881-8. doi: 10.1128/JVI.69.5.2881-2888.1995.
9
Equine infectious anemia virus resists the antiretroviral activity of equine APOBEC3 proteins through a packaging-independent mechanism.马传染性贫血病毒通过一种不依赖包装的机制抵抗马载脂蛋白B mRNA编辑酶催化多肽样蛋白3（APOBEC3）的抗逆转录病毒活性。
J Virol. 2008 Dec;82(23):11889-901. doi: 10.1128/JVI.01537-08. Epub 2008 Sep 25.
10
An in vitro transcription system that recapitulates equine infectious anemia virus tat-mediated inhibition of human immunodeficiency virus type 1 Tat activity demonstrates a role for positive transcription elongation factor b and associated proteins in the mechanism of Tat activation.一种体外转录系统可重现马传染性贫血病毒tat介导的对1型人类免疫缺陷病毒Tat活性的抑制作用，该系统证明了正转录延伸因子b及相关蛋白在Tat激活机制中的作用。
Virology. 2000 Sep 1;274(2):356-66. doi: 10.1006/viro.2000.0480.

引用本文的文献

1
Perspectives on biologically active camptothecin derivatives.生物活性喜树碱衍生物的研究视角
Med Res Rev. 2015 Jul;35(4):753-89. doi: 10.1002/med.21342. Epub 2015 Mar 21.
2
Reverse Transcriptase and Cellular Factors: Regulators of HIV-1 Reverse Transcription.逆转录酶和细胞因子：HIV-1 逆转录的调节因子。
Viruses. 2009 Dec;1(3):873-94. doi: 10.3390/v1030873. Epub 2009 Nov 10.
3
ATPgammaS disrupts human immunodeficiency virus type 1 virion core integrity.三磷酸腺苷γ-硫代磷酸酯破坏1型人类免疫缺陷病毒病毒粒子核心的完整性。

本文引用的文献

1
Higher order metaphase chromosome structure: evidence for metalloprotein interactions.高阶中期染色体结构：金属蛋白相互作用的证据。
Cell. 1982 May;29(1):171-81. doi: 10.1016/0092-8674(82)90101-5.
2
A comprehensive set of sequence analysis programs for the VAX.一套适用于VAX的综合序列分析程序。
Nucleic Acids Res. 1984 Jan 11;12(1 Pt 1):387-95. doi: 10.1093/nar/12.1part1.387.
3
Intracellular distribution of DNA topoisomerase I in fibroblasts from patients with Fanconi's anaemia.范可尼贫血患者成纤维细胞中DNA拓扑异构酶I的细胞内分布
J Virol. 2005 May;79(9):5557-67. doi: 10.1128/JVI.79.9.5557-5567.2005.
4
Role for human immunodeficiency virus type 1 Tat protein in suppression of viral reverse transcriptase activity during late stages of viral replication.人类免疫缺陷病毒1型反式激活因子（Tat蛋白）在病毒复制后期抑制病毒逆转录酶活性中的作用。
J Virol. 2001 Mar;75(6):2675-83. doi: 10.1128/JVI.75.6.2675-2683.2001.
5
Functional domains of Tat required for efficient human immunodeficiency virus type 1 reverse transcription.1型人类免疫缺陷病毒高效逆转录所需的Tat功能域。
J Virol. 1999 Mar;73(3):2499-508. doi: 10.1128/JVI.73.3.2499-2508.1999.
6
Tat is required for efficient HIV-1 reverse transcription.Tat是高效HIV-1逆转录所必需的。
EMBO J. 1997 Mar 17;16(6):1224-35. doi: 10.1093/emboj/16.6.1224.
7
Three inhibitors of type 1 human immunodeficiency virus long terminal repeat-directed gene expression and virus replication.三种1型人类免疫缺陷病毒长末端重复序列定向基因表达和病毒复制的抑制剂。
Proc Natl Acad Sci U S A. 1993 Mar 1;90(5):1839-42. doi: 10.1073/pnas.90.5.1839.
8
Inhibition of retrovirus-induced disease in mice by camptothecin.喜树碱对小鼠逆转录病毒诱导疾病的抑制作用。
J Virol. 1993 Jun;67(6):3624-9. doi: 10.1128/JVI.67.6.3624-3629.1993.
9
T cell proliferative response induced by DNA topoisomerase I in patients with systemic sclerosis and healthy donors.系统性硬化症患者和健康供体中DNA拓扑异构酶I诱导的T细胞增殖反应。
J Clin Invest. 1995 Jul;96(1):586-96. doi: 10.1172/JCI118071.
10
Human immunodeficiency virus type 1 reverse transcriptase: enhancement of activity by interaction with cellular topoisomerase I.1型人类免疫缺陷病毒逆转录酶：与细胞拓扑异构酶I相互作用增强活性
Proc Natl Acad Sci U S A. 1995 Jun 6;92(12):5694-8. doi: 10.1073/pnas.92.12.5694.
Hum Genet. 1982;61(4):369-71. doi: 10.1007/BF00276603.
4
The pUC plasmids, an M13mp7-derived system for insertion mutagenesis and sequencing with synthetic universal primers.pUC质粒，一种源自M13mp7的用于插入诱变和使用合成通用引物进行测序的系统。
Gene. 1982 Oct;19(3):259-68. doi: 10.1016/0378-1119(82)90015-4.
5
Isolation and partial characterization of two distinct DNA topoisomerases from cauliflower inflorescence.从菜花花序中分离出两种不同的DNA拓扑异构酶并进行部分特性分析。
J Biochem. 1982 Apr;91(4):1337-42. doi: 10.1093/oxfordjournals.jbchem.a133820.
6
DNA topoisomerase activity associated with Rous sarcoma virus.与劳氏肉瘤病毒相关的DNA拓扑异构酶活性
Virology. 1981 Oct 30;114(2):563-6. doi: 10.1016/0042-6822(81)90236-1.
7
Purification and characterization of wheat germ DNA topoisomerase I (nicking-closing enzyme).小麦胚DNA拓扑异构酶I（切口-封闭酶）的纯化与特性分析
J Biol Chem. 1981 Jun 10;256(11):5860-5.
8
Purification and characterization of Xenopus laevis type I topoisomerase.非洲爪蟾I型拓扑异构酶的纯化与特性分析
J Biol Chem. 1981 Apr 25;256(8):3654-61.
9
Identification, developmental regulation, and response to heat shock of two antigenically related forms of a major nuclear envelope protein in Drosophila embryos: application of an improved method for affinity purification of antibodies using polypeptides immobilized on nitrocellulose blots.果蝇胚胎中一种主要核被膜蛋白的两种抗原相关形式的鉴定、发育调控及对热休克的反应：利用固定在硝酸纤维素印迹上的多肽改进抗体亲和纯化方法的应用
J Cell Biol. 1984 Jul;99(1 Pt 1):20-8. doi: 10.1083/jcb.99.1.20.
10
Drosophila DNA topoisomerase I is associated with transcriptionally active regions of the genome.果蝇DNA拓扑异构酶I与基因组的转录活性区域相关联。
Proc Natl Acad Sci U S A. 1984 Nov;81(22):6958-62. doi: 10.1073/pnas.81.22.6958.